Gene Symbol | Gene ID | Gene Info |
---|---|---|
POU2F1
|
ENSG00000143190.17 | POU class 2 homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr1_167191913_167192064 | POU2F1 | 1845 | 0.295132 | 0.75 | 1.9e-02 | Click! |
chr1_167190838_167191161 | POU2F1 | 856 | 0.481501 | 0.61 | 8.3e-02 | Click! |
chr1_167298272_167298450 | POU2F1 | 80 | 0.978664 | -0.58 | 9.9e-02 | Click! |
chr1_167190163_167190484 | POU2F1 | 180 | 0.826179 | 0.46 | 2.1e-01 | Click! |
chr1_167192535_167192686 | POU2F1 | 2467 | 0.251514 | 0.45 | 2.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_121298288_121298439 | 1.97 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
24549 |
0.21 |
chrX_78400540_78401325 | 1.75 |
GPR174 |
G protein-coupled receptor 174 |
25537 |
0.27 |
chr14_22968352_22968523 | 1.69 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
12266 |
0.1 |
chr11_6766362_6766695 | 1.44 |
GVINP1 |
GTPase, very large interferon inducible pseudogene 1 |
23417 |
0.11 |
chr7_150436038_150436258 | 1.43 |
GIMAP5 |
GTPase, IMAP family member 5 |
1712 |
0.32 |
chr7_50351765_50352753 | 1.32 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
3941 |
0.34 |
chr5_156608214_156608444 | 1.31 |
ITK |
IL2-inducible T-cell kinase |
492 |
0.72 |
chr9_105944429_105944580 | 1.25 |
CYLC2 |
cylicin, basic protein of sperm head cytoskeleton 2 |
186878 |
0.03 |
chr4_109084692_109084886 | 1.23 |
LEF1 |
lymphoid enhancer-binding factor 1 |
2668 |
0.31 |
chr10_22622036_22622322 | 1.21 |
BMI1 |
BMI1 polycomb ring finger oncogene |
6731 |
0.15 |
chr4_78737672_78737823 | 1.21 |
CNOT6L |
CCR4-NOT transcription complex, subunit 6-like |
2470 |
0.38 |
chr2_204806282_204806433 | 1.20 |
ICOS |
inducible T-cell co-stimulator |
4854 |
0.31 |
chr2_120687963_120688114 | 1.19 |
PTPN4 |
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) |
686 |
0.74 |
chr17_29639732_29640055 | 1.18 |
EVI2B |
ecotropic viral integration site 2B |
1209 |
0.36 |
chr3_60066140_60066307 | 1.17 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
108640 |
0.08 |
chr11_3010488_3011464 | 1.17 |
AC131971.1 |
HCG1782999; PRO0943; Uncharacterized protein |
117 |
0.83 |
chr5_130883505_130884015 | 1.16 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
15034 |
0.29 |
chr3_108549304_108549455 | 1.13 |
TRAT1 |
T cell receptor associated transmembrane adaptor 1 |
7760 |
0.27 |
chr1_198610531_198610895 | 1.11 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
2421 |
0.36 |
chr16_22021511_22021662 | 1.10 |
C16orf52 |
chromosome 16 open reading frame 52 |
1982 |
0.29 |
chr18_56326442_56326593 | 1.09 |
MALT1 |
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
12101 |
0.14 |
chr1_209943452_209943666 | 1.08 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1599 |
0.29 |
chr14_99702038_99702570 | 1.08 |
AL109767.1 |
|
26981 |
0.19 |
chr12_109026876_109027027 | 1.06 |
SELPLG |
selectin P ligand |
719 |
0.55 |
chr17_46504918_46505069 | 1.06 |
SKAP1 |
src kinase associated phosphoprotein 1 |
2559 |
0.22 |
chr12_103834650_103834908 | 1.04 |
C12orf42 |
chromosome 12 open reading frame 42 |
54952 |
0.15 |
chr21_43824605_43824850 | 1.04 |
UBASH3A |
ubiquitin associated and SH3 domain containing A |
701 |
0.58 |
chr6_144665292_144666004 | 1.03 |
UTRN |
utrophin |
411 |
0.88 |
chr17_19031223_19031746 | 1.02 |
GRAPL |
GRB2-related adaptor protein-like |
636 |
0.51 |
chr7_38386000_38386394 | 1.02 |
AMPH |
amphiphysin |
116516 |
0.06 |
chr14_98442707_98443118 | 1.01 |
C14orf64 |
chromosome 14 open reading frame 64 |
1471 |
0.59 |
chr19_42390602_42391041 | 1.00 |
ARHGEF1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
2306 |
0.19 |
chr7_38399403_38399654 | 1.00 |
AMPH |
amphiphysin |
103185 |
0.08 |
chr2_197065951_197066345 | 0.99 |
ENSG00000239161 |
. |
13898 |
0.18 |
chr17_18949450_18949786 | 0.99 |
GRAP |
GRB2-related adaptor protein |
692 |
0.54 |
chr12_27093749_27094602 | 0.98 |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
2742 |
0.2 |
chr1_25889724_25889930 | 0.97 |
LDLRAP1 |
low density lipoprotein receptor adaptor protein 1 |
19756 |
0.18 |
chr7_26193443_26193677 | 0.97 |
NFE2L3 |
nuclear factor, erythroid 2-like 3 |
1700 |
0.36 |
chr3_18477572_18477723 | 0.96 |
SATB1 |
SATB homeobox 1 |
902 |
0.62 |
chr10_13382497_13382864 | 0.96 |
SEPHS1 |
selenophosphate synthetase 1 |
110 |
0.97 |
chr21_26829625_26829997 | 0.95 |
ENSG00000238314 |
. |
12702 |
0.26 |
chr7_38392270_38392581 | 0.94 |
AMPH |
amphiphysin |
110288 |
0.07 |
chr21_35304396_35305066 | 0.94 |
LINC00649 |
long intergenic non-protein coding RNA 649 |
1213 |
0.41 |
chr19_54875637_54875913 | 0.94 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
639 |
0.57 |
chr6_144376227_144376378 | 0.91 |
PLAGL1 |
pleiomorphic adenoma gene-like 1 |
9433 |
0.25 |
chr18_2659637_2659788 | 0.90 |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
3826 |
0.19 |
chr17_33566033_33566184 | 0.89 |
RP11-799D4.4 |
|
1108 |
0.42 |
chrX_78403660_78403811 | 0.88 |
GPR174 |
G protein-coupled receptor 174 |
22734 |
0.28 |
chrX_78196699_78196850 | 0.88 |
P2RY10 |
purinergic receptor P2Y, G-protein coupled, 10 |
4055 |
0.37 |
chr2_235401897_235402222 | 0.88 |
ARL4C |
ADP-ribosylation factor-like 4C |
3185 |
0.41 |
chr17_74749862_74750103 | 0.88 |
ENSG00000200257 |
. |
988 |
0.35 |
chr17_33571051_33571291 | 0.88 |
SLFN5 |
schlafen family member 5 |
1063 |
0.35 |
chr14_101120700_101120851 | 0.87 |
CTD-2644I21.1 |
|
65112 |
0.06 |
chr7_21470215_21470407 | 0.86 |
SP4 |
Sp4 transcription factor |
2650 |
0.27 |
chr7_151573941_151574218 | 0.85 |
PRKAG2-AS1 |
PRKAG2 antisense RNA 1 |
48 |
0.6 |
chr12_90693017_90693168 | 0.85 |
ENSG00000252823 |
. |
545256 |
0.0 |
chr1_197711455_197711606 | 0.85 |
DENND1B |
DENN/MADD domain containing 1B |
6763 |
0.23 |
chr1_160681036_160681588 | 0.85 |
CD48 |
CD48 molecule |
281 |
0.89 |
chr1_167600522_167600685 | 0.85 |
RP3-455J7.4 |
|
692 |
0.53 |
chr13_49832065_49832609 | 0.85 |
CDADC1 |
cytidine and dCMP deaminase domain containing 1 |
10153 |
0.23 |
chr14_61809095_61809246 | 0.85 |
PRKCH |
protein kinase C, eta |
1790 |
0.38 |
chr16_50780900_50781420 | 0.84 |
CYLD |
cylindromatosis (turban tumor syndrome) |
2300 |
0.18 |
chr1_206732541_206732911 | 0.84 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
2233 |
0.27 |
chr1_111417492_111418003 | 0.84 |
CD53 |
CD53 molecule |
1971 |
0.34 |
chr7_87318553_87318704 | 0.84 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
23936 |
0.21 |
chr1_239883177_239883989 | 0.84 |
CHRM3 |
cholinergic receptor, muscarinic 3 |
740 |
0.59 |
chr18_9117636_9118003 | 0.84 |
RP11-143J12.3 |
|
1944 |
0.28 |
chr14_97879221_97879798 | 0.84 |
ENSG00000240730 |
. |
117001 |
0.07 |
chr13_41589998_41590808 | 0.83 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
3047 |
0.26 |
chr14_22998410_22998561 | 0.83 |
TRAJ15 |
T cell receptor alpha joining 15 |
95 |
0.94 |
chr13_97874593_97875664 | 0.83 |
MBNL2 |
muscleblind-like splicing regulator 2 |
519 |
0.87 |
chr8_126958884_126959035 | 0.82 |
ENSG00000206695 |
. |
45764 |
0.2 |
chr2_201248196_201249000 | 0.82 |
ENSG00000264798 |
. |
3300 |
0.23 |
chr14_22960619_22960887 | 0.82 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
4582 |
0.12 |
chr14_61793464_61793615 | 0.81 |
PRKCH |
protein kinase C, eta |
92 |
0.97 |
chr3_114013339_114013497 | 0.81 |
TIGIT |
T cell immunoreceptor with Ig and ITIM domains |
416 |
0.84 |
chr3_38494178_38494329 | 0.81 |
ACVR2B |
activin A receptor, type IIB |
1089 |
0.44 |
chr1_192545263_192545458 | 0.81 |
RGS1 |
regulator of G-protein signaling 1 |
457 |
0.84 |
chr12_25207113_25207806 | 0.79 |
LRMP |
lymphoid-restricted membrane protein |
1785 |
0.37 |
chr1_93003097_93003248 | 0.79 |
GFI1 |
growth factor independent 1 transcription repressor |
50739 |
0.15 |
chr14_106471583_106471884 | 0.79 |
IGHV1-3 |
immunoglobulin heavy variable 1-3 |
10 |
0.91 |
chr1_206644983_206645179 | 0.79 |
IKBKE |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
1243 |
0.39 |
chr10_73869476_73869627 | 0.79 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
20761 |
0.19 |
chr13_49064231_49064382 | 0.79 |
RCBTB2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
42907 |
0.17 |
chr10_62493530_62493681 | 0.79 |
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
357 |
0.92 |
chr1_114413159_114413365 | 0.79 |
PTPN22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
1058 |
0.4 |
chr10_121412015_121412434 | 0.78 |
BAG3 |
BCL2-associated athanogene 3 |
1342 |
0.5 |
chr13_52398191_52398536 | 0.78 |
RP11-327P2.5 |
|
19930 |
0.17 |
chr15_45005481_45005930 | 0.78 |
B2M |
beta-2-microglobulin |
1990 |
0.25 |
chr14_100532787_100533367 | 0.78 |
EVL |
Enah/Vasp-like |
303 |
0.88 |
chr14_22972981_22973242 | 0.78 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
16940 |
0.09 |
chr4_124343109_124343622 | 0.77 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
22242 |
0.29 |
chr14_99708034_99708225 | 0.77 |
AL109767.1 |
|
21156 |
0.2 |
chr4_186177003_186177154 | 0.77 |
SNX25 |
sorting nexin 25 |
45845 |
0.12 |
chr3_156271681_156272482 | 0.77 |
SSR3 |
signal sequence receptor, gamma (translocon-associated protein gamma) |
167 |
0.96 |
chr1_101784802_101784953 | 0.77 |
RP4-575N6.5 |
|
76163 |
0.09 |
chr2_175461579_175461860 | 0.77 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
774 |
0.64 |
chr8_113763690_113763841 | 0.76 |
CSMD3 |
CUB and Sushi multiple domains 3 |
61494 |
0.15 |
chr1_241715487_241715755 | 0.76 |
KMO |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
16314 |
0.2 |
chrX_78401406_78401924 | 0.76 |
GPR174 |
G protein-coupled receptor 174 |
24804 |
0.27 |
chr13_46750556_46750707 | 0.76 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
5828 |
0.17 |
chr16_16055390_16055590 | 0.76 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
12056 |
0.21 |
chr3_31588723_31588874 | 0.76 |
STT3B |
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
14516 |
0.29 |
chr12_783207_783358 | 0.75 |
NINJ2 |
ninjurin 2 |
10337 |
0.19 |
chr14_51290610_51290880 | 0.75 |
NIN |
ninein (GSK3B interacting protein) |
1971 |
0.23 |
chr4_80388099_80388250 | 0.75 |
GK2 |
glycerol kinase 2 |
58802 |
0.15 |
chr8_23312978_23313222 | 0.74 |
ENTPD4 |
ectonucleoside triphosphate diphosphohydrolase 4 |
2060 |
0.32 |
chr12_104854519_104854691 | 0.74 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
3826 |
0.33 |
chr12_103835002_103835156 | 0.74 |
C12orf42 |
chromosome 12 open reading frame 42 |
54652 |
0.15 |
chr2_99345755_99346000 | 0.73 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
834 |
0.68 |
chr16_50874988_50875494 | 0.73 |
ENSG00000199771 |
. |
28245 |
0.15 |
chr2_192014047_192014198 | 0.73 |
STAT4 |
signal transducer and activator of transcription 4 |
1575 |
0.44 |
chr8_126946495_126946646 | 0.73 |
ENSG00000206695 |
. |
33375 |
0.25 |
chr7_28369849_28370167 | 0.73 |
CREB5 |
cAMP responsive element binding protein 5 |
31068 |
0.23 |
chr14_61644965_61645116 | 0.72 |
PRKCH |
protein kinase C, eta |
9237 |
0.26 |
chr6_130898558_130898709 | 0.72 |
ENSG00000202438 |
. |
3376 |
0.37 |
chr1_89737127_89737489 | 0.72 |
GBP5 |
guanylate binding protein 5 |
762 |
0.66 |
chr17_33863414_33863594 | 0.72 |
SLFN12L |
schlafen family member 12-like |
1376 |
0.29 |
chr7_2550958_2551215 | 0.72 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
1077 |
0.47 |
chr1_66800579_66801197 | 0.72 |
PDE4B |
phosphodiesterase 4B, cAMP-specific |
3016 |
0.39 |
chr13_99911056_99911338 | 0.72 |
GPR18 |
G protein-coupled receptor 18 |
515 |
0.8 |
chr3_151965779_151965930 | 0.72 |
MBNL1 |
muscleblind-like splicing regulator 1 |
19975 |
0.21 |
chr21_36414032_36414216 | 0.71 |
RUNX1 |
runt-related transcription factor 1 |
7338 |
0.33 |
chr2_99273254_99273405 | 0.71 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
6607 |
0.23 |
chr9_102972411_102972625 | 0.71 |
ENSG00000239908 |
. |
107677 |
0.06 |
chr2_111616711_111616862 | 0.71 |
ACOXL |
acyl-CoA oxidase-like |
53890 |
0.17 |
chr8_126017214_126017365 | 0.71 |
SQLE |
squalene epoxidase |
4233 |
0.19 |
chr7_52789859_52790010 | 0.71 |
POM121L12 |
POM121 transmembrane nucleoporin-like 12 |
313415 |
0.01 |
chr1_84611671_84611822 | 0.71 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1792 |
0.48 |
chr14_51258696_51258847 | 0.71 |
NIN |
ninein (GSK3B interacting protein) |
25258 |
0.13 |
chr14_58714715_58714866 | 0.70 |
PSMA3 |
proteasome (prosome, macropain) subunit, alpha type, 3 |
3168 |
0.16 |
chr3_194490197_194490679 | 0.70 |
FAM43A |
family with sequence similarity 43, member A |
83816 |
0.08 |
chr3_151990400_151990939 | 0.70 |
MBNL1-AS1 |
MBNL1 antisense RNA 1 |
3325 |
0.26 |
chr2_197030897_197031094 | 0.70 |
STK17B |
serine/threonine kinase 17b |
4729 |
0.22 |
chr4_100738344_100738640 | 0.70 |
DAPP1 |
dual adaptor of phosphotyrosine and 3-phosphoinositides |
489 |
0.85 |
chr3_32993381_32993532 | 0.70 |
CCR4 |
chemokine (C-C motif) receptor 4 |
390 |
0.9 |
chr14_22994017_22994177 | 0.69 |
TRAJ15 |
T cell receptor alpha joining 15 |
4483 |
0.13 |
chr14_92331424_92331867 | 0.69 |
TC2N |
tandem C2 domains, nuclear |
2228 |
0.32 |
chr2_54222062_54222361 | 0.69 |
ACYP2 |
acylphosphatase 2, muscle type |
23966 |
0.18 |
chr1_108477311_108477544 | 0.69 |
VAV3-AS1 |
VAV3 antisense RNA 1 |
29638 |
0.19 |
chr8_18588240_18588391 | 0.69 |
RP11-161I2.1 |
|
9900 |
0.25 |
chr2_158296227_158296378 | 0.69 |
CYTIP |
cytohesin 1 interacting protein |
376 |
0.85 |
chr1_31234118_31234269 | 0.68 |
LAPTM5 |
lysosomal protein transmembrane 5 |
3526 |
0.21 |
chr6_159464058_159464225 | 0.68 |
TAGAP |
T-cell activation RhoGTPase activating protein |
1909 |
0.34 |
chr5_6828115_6828430 | 0.68 |
ENSG00000200243 |
. |
20303 |
0.27 |
chr11_128161993_128162144 | 0.68 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
213221 |
0.02 |
chr7_33078848_33079779 | 0.68 |
NT5C3A |
5'-nucleotidase, cytosolic IIIA |
1208 |
0.42 |
chr20_43599328_43599508 | 0.68 |
STK4 |
serine/threonine kinase 4 |
4251 |
0.17 |
chr1_198609082_198609240 | 0.68 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
869 |
0.68 |
chr8_82011756_82011907 | 0.68 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
12472 |
0.28 |
chr1_206731284_206731580 | 0.67 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
939 |
0.54 |
chr1_116521911_116522382 | 0.67 |
SLC22A15 |
solute carrier family 22, member 15 |
2911 |
0.32 |
chr3_164293580_164293731 | 0.67 |
ENSG00000221755 |
. |
234526 |
0.02 |
chr10_14643816_14644958 | 0.67 |
FAM107B |
family with sequence similarity 107, member B |
2001 |
0.38 |
chr17_37948516_37948667 | 0.67 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
14113 |
0.14 |
chr1_101703704_101704393 | 0.67 |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
1604 |
0.28 |
chr12_12873301_12873452 | 0.66 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
2581 |
0.19 |
chr2_27995064_27995342 | 0.66 |
MRPL33 |
mitochondrial ribosomal protein L33 |
619 |
0.69 |
chr1_39499733_39499961 | 0.66 |
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) |
7857 |
0.18 |
chr2_213977055_213977206 | 0.66 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
36223 |
0.21 |
chr12_22200039_22200341 | 0.66 |
CMAS |
cytidine monophosphate N-acetylneuraminic acid synthetase |
1082 |
0.65 |
chr14_99736851_99737002 | 0.66 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
639 |
0.75 |
chr20_35578714_35579204 | 0.65 |
SAMHD1 |
SAM domain and HD domain 1 |
1152 |
0.54 |
chr5_90678270_90678948 | 0.65 |
ARRDC3 |
arrestin domain containing 3 |
567 |
0.83 |
chr12_25206187_25206540 | 0.65 |
LRMP |
lymphoid-restricted membrane protein |
689 |
0.71 |
chr10_26728445_26728931 | 0.65 |
APBB1IP |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
1334 |
0.57 |
chr4_39032922_39033274 | 0.65 |
TMEM156 |
transmembrane protein 156 |
943 |
0.6 |
chr5_118606441_118606592 | 0.65 |
TNFAIP8 |
tumor necrosis factor, alpha-induced protein 8 |
2067 |
0.32 |
chr1_198633706_198634133 | 0.64 |
RP11-553K8.5 |
|
2271 |
0.37 |
chr6_143227809_143227960 | 0.64 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
38454 |
0.19 |
chr12_47606694_47606931 | 0.64 |
PCED1B |
PC-esterase domain containing 1B |
3240 |
0.28 |
chr4_122148073_122148224 | 0.64 |
TNIP3 |
TNFAIP3 interacting protein 3 |
473 |
0.85 |
chr7_21471147_21471369 | 0.64 |
SP4 |
Sp4 transcription factor |
3597 |
0.23 |
chr10_63999461_63999612 | 0.64 |
RTKN2 |
rhotekin 2 |
3514 |
0.34 |
chr7_105172345_105172532 | 0.64 |
RINT1 |
RAD50 interactor 1 |
94 |
0.97 |
chr1_51981132_51981283 | 0.63 |
RP11-191G24.1 |
|
2774 |
0.21 |
chr5_180616370_180616680 | 0.63 |
CTC-338M12.5 |
|
2399 |
0.13 |
chr7_150382525_150383418 | 0.63 |
GIMAP2 |
GTPase, IMAP family member 2 |
156 |
0.95 |
chr5_34651341_34651492 | 0.63 |
RAI14 |
retinoic acid induced 14 |
4926 |
0.25 |
chr4_102712668_102712913 | 0.63 |
BANK1 |
B-cell scaffold protein with ankyrin repeats 1 |
903 |
0.72 |
chr7_38381792_38381992 | 0.63 |
AMPH |
amphiphysin |
120821 |
0.06 |
chr18_9120826_9120977 | 0.63 |
RP11-143J12.3 |
|
5026 |
0.17 |
chr1_25254722_25254968 | 0.63 |
RUNX3 |
runt-related transcription factor 3 |
767 |
0.7 |
chr13_41556565_41556847 | 0.63 |
ELF1 |
E74-like factor 1 (ets domain transcription factor) |
288 |
0.92 |
chr8_87356076_87356655 | 0.63 |
WWP1 |
WW domain containing E3 ubiquitin protein ligase 1 |
1398 |
0.54 |
chr10_7793124_7793275 | 0.63 |
KIN |
KIN, antigenic determinant of recA protein homolog (mouse) |
36745 |
0.14 |
chr9_273424_273720 | 0.63 |
DOCK8 |
dedicator of cytokinesis 8 |
502 |
0.5 |
chr13_99891034_99891185 | 0.62 |
GPR18 |
G protein-coupled receptor 18 |
19519 |
0.17 |
chr1_198608305_198608501 | 0.62 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
111 |
0.98 |
chr13_42624018_42624169 | 0.62 |
DGKH |
diacylglycerol kinase, eta |
1204 |
0.52 |
chr17_33571906_33572066 | 0.62 |
SLFN5 |
schlafen family member 5 |
1878 |
0.24 |
chr6_42014239_42014398 | 0.62 |
CCND3 |
cyclin D3 |
2106 |
0.26 |
chr7_19140120_19140271 | 0.62 |
AC003986.6 |
|
11902 |
0.16 |
chr13_110431430_110431600 | 0.62 |
IRS2 |
insulin receptor substrate 2 |
7400 |
0.28 |
chr1_234492762_234493310 | 0.62 |
RP5-827C21.2 |
|
284 |
0.88 |
chr6_95260200_95260351 | 0.62 |
ENSG00000252249 |
. |
671451 |
0.0 |
chr16_75836248_75836399 | 0.62 |
ENSG00000199299 |
. |
58732 |
0.12 |
chr4_89742772_89743117 | 0.61 |
FAM13A |
family with sequence similarity 13, member A |
1408 |
0.53 |
chr6_149643931_149644082 | 0.61 |
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
1818 |
0.37 |
chr7_7960484_7960678 | 0.61 |
ENSG00000201747 |
. |
14431 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.8 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.4 | 1.2 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.3 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.3 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.2 | 0.7 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 2.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.4 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.2 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.6 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.2 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.5 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 0.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 1.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.3 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 | 0.2 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.2 | 0.5 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.4 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.4 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.1 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.4 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.1 | 0.4 | GO:1901722 | regulation of cell proliferation involved in kidney development(GO:1901722) |
0.1 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.3 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.9 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 1.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.5 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.3 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 0.4 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.4 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.5 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.1 | 0.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.2 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 4.6 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.3 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 0.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.1 | 0.1 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.3 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.1 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.1 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 1.1 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.1 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.3 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 1.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.2 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 1.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0043247 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.1 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.5 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0019043 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.1 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.2 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.0 | 0.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.0 | 0.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.1 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.0 | 0.2 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.1 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.2 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0046719 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.1 | GO:0031665 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.2 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.4 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.2 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.4 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.0 | GO:0032823 | natural killer cell differentiation(GO:0001779) regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 2.5 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.0 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.0 | 0.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.0 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.0 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.0 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.0 | 0.1 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.1 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.9 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.0 | 0.1 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0033087 | regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.0 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.0 | 0.9 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.2 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.0 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.1 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.0 | 0.2 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.5 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.1 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.0 | 1.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0033235 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.0 | 1.2 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.0 | 0.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.2 | GO:0048194 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) regulation of apoptotic process involved in morphogenesis(GO:1902337) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) regulation of apoptotic process involved in development(GO:1904748) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.0 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 1.0 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0042723 | thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0032692 | negative regulation of interleukin-1 production(GO:0032692) |
0.0 | 0.1 | GO:0071675 | regulation of macrophage chemotaxis(GO:0010758) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.2 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.9 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0010800 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.1 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.2 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.0 | 0.1 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.0 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 0.1 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.0 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.0 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.3 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0034311 | diol metabolic process(GO:0034311) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.3 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 2.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.0 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.2 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 2.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.0 | 2.9 | GO:0016568 | chromatin modification(GO:0016568) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.0 | 0.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.0 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.3 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.0 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.0 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.0 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.0 | 0.0 | GO:0022605 | oogenesis stage(GO:0022605) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.0 | 0.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.0 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.0 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 1.2 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.1 | GO:0021532 | neural tube patterning(GO:0021532) |
0.0 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.0 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.0 | 0.4 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.0 | 0.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.0 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.6 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.4 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0000090 | mitotic anaphase(GO:0000090) |
0.0 | 0.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.1 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.0 | 0.0 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.0 | GO:0035588 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.6 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.0 | 0.0 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.1 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.0 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.0 | 0.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.0 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.0 | 0.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.0 | GO:0021610 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.0 | 0.0 | GO:0051279 | regulation of release of sequestered calcium ion into cytosol(GO:0051279) |
0.0 | 0.0 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 1.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 0.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.6 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.5 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.5 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 2.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.9 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 1.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.4 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 2.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.6 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.6 | GO:0042611 | MHC protein complex(GO:0042611) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 1.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 1.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 2.6 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.6 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.0 | 0.0 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0030288 | outer membrane-bounded periplasmic space(GO:0030288) cell envelope(GO:0030313) periplasmic space(GO:0042597) |
0.0 | 0.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 1.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 2.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.2 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.6 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.0 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.5 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 1.8 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.0 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 1.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.1 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.7 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 3.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 2.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 2.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.4 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.2 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.7 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.2 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.1 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 2.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 1.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.2 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.2 | GO:0004396 | hexokinase activity(GO:0004396) |
0.0 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.6 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.4 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.9 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.2 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.3 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.0 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.0 | 1.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.1 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.3 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.0 | 0.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.5 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 1.7 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.2 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 1.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 3.6 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.1 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.3 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.0 | 0.1 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.0 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 2.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 1.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.4 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 4.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.0 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 2.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.8 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.6 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.0 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.0 | 0.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |